Back

Oral iron supplementation with ferric maltol improves iron deficiency anaemia in patients with chronic heart failure

18 May 2025 (13:55 - 14:05)
Organised by: Logo
Congress Presentation Part of: Late-breaking clinical trials in chronic heart failure Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Tibor Kempf

Hannover Medical School, Hannover (Germany)

5 More presentations in this session

Presentation thumbnail
Safety and tolerability of diuretics withdrawal in patients with heart failure with reduced ejection fraction. REDICAE trial
Doctor J. Torres Zamudio (Cordoba, ES)
Slides Video
Presentation thumbnail
Gene therapy for heart failure with preserved ejection fraction
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
NAN-CS101: A first-in-human Phase 1 open-label dose-escalation study of AB-1002 gene therapy for the treatment of NYHA class III heart failure
Doctor R. Hajjar (Boston, US)
Slides Video
Presentation thumbnail
Finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomized placebo-controlled mechanistic trial (FIVE-STAR)
Professor A. Tanaka (Saga, JP)
Slides Video
Presentation thumbnail
Cardio-microcurrent device for chronic heart failure: results from the C-MIC II randomized controlled trial
Professor S. Anker (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
Late-breaking clinical trials in chronic heart failure
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 13:55 CET
You may be interested in
thumbnail
Congress Presentation
New IV iron trials
thumbnail
Congress Presentation
Ferric derisomaltose: IRONMAN
thumbnail
Congress Session
Late breaking clinical trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources